The agency announced Aug. 17 that it is lifting its previous suspension of routine inspections. Certain inspections were suspended at the end of March to prioritize infection control and immediate jeopardy situations and to give healthcare providers and suppliers time to respond to the COVID-19 pandemic.
CMS said it will resume on-site revisit surveys, nonimmediate jeopardy complaint surveys and annual recertification surveys as soon as resources are available.
In addition, CMS is temporarily expanding its desk review policy, which enables state surveyors to ensure that facilities become compliant with federal requirements without an on-site survey. The policy will now be expanded to include all noncompliance reviews except for immediate jeopardy citations that have not been removed.
Read more here.
More articles on patient safety & outcomes:
COVID-19 survivors identify 98 lingering effects
1 in 3 patients may have neurological issues after COVID-19, experts say
Dartmouth-Hitchcock performs 1,000th transplant
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
